It suits people who value convenience, medication delivery, and clinical follow up via app messaging
Now, a new study presented at the American Diabetes Associations Scientific Session 2026 and published in the journal This study presented findings from a phase 2b randomized clinical trial called SOLSTICE to test the new oral GLP-1 medication elecoglipron
The goal of weight loss is not to fit into a skinnier casket
Protocol was completed in 7 steps in approximately 3 h, with the aim of reaching the daily dosage of exenatide
thats how youll get prequalified for a GLP-1
You may not be a fit if youre pregnant, trying to become pregnant, breastfeeding, have certain gastrointestinal conditions, have a history of specific endocrine cancers, or have other medical factors that make GLP-1 treatment inappropriate